首页> 美国卫生研究院文献>Scientific Reports >CETP genetic variant rs1800777 (allele A) is associated with abnormally low HDL-C levels and increased risk of AKI during sepsis
【2h】

CETP genetic variant rs1800777 (allele A) is associated with abnormally low HDL-C levels and increased risk of AKI during sepsis

机译:CETP遗传变异体rs1800777(等位基因A)与脓毒症期间HDL-C水平异常低和AKI风险增加有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

High-density cholesterol (HDL-C) levels are influenced by genetic variation in several genes. Low levels of HDL-C have been associated with increased risk of acute kidney injury (AKI). We investigated whether genetic polymorphisms in ten genes known to regulate HDL-C levels are associated with both HDL-C levels and AKI development during sepsis. Two cohorts were retrospectively analyzed: Derivation Cohort (202 patients with sepsis enrolled at the Emergency Department from 2011 to 2014 in Vancouver, Canada); Validation Cohort (604 septic shock patients enrolled into the Vasopressin in Septic Shock Trial (VASST)). Associations between HDL-related genetic polymorphisms and both HDL-C levels, and risk for clinically significant sepsis-associated AKI (AKI KDIGO stages 2 and 3) were evaluated. In the Derivation Cohort, one genetic variant in the Cholesteryl Ester Transfer Protein (CETP) gene, rs1800777 (allele A), was strongly associated with lower HDL-C levels (17.4 mg/dL vs. 32.9 mg/dL, P = 0.002), greater CETP mass (3.43 µg/mL vs. 1.32 µg/mL, P = 0.034), and increased risk of clinically significant sepsis-associated AKI (OR: 8.28, p = 0.013). Moreover, the same allele was a predictor of sepsis-associated AKI in the Validation Cohort (OR: 2.38, p = 0.020). Our findings suggest that CETP modulates HDL-C levels in sepsis. CETP genotype may identify patients at high-risk of sepsis-associated AKI.
机译:高密度胆固醇(HDL-C)水平受几种基因的遗传变异影响。低水平的HDL-C与急性肾损伤(AKI)的风险增加有关。我们调查了败血症过程中已知调控HDL-C水平的10个基因中的遗传多态性是否与HDL-C水平和AKI发育相关。回顾性分析了两个队列:衍生队列(2011年至2014年在加拿大温哥华的急诊科招募了202名脓毒症患者);验证队列(604名败血症休克患者参加了败血症休克试验(VASST)中的加压加压素治疗)。评估了与HDL相关的基因多态性与HDL-C水平和临床上与脓毒症相关的AKI(AKI KDIGO 2和3期)的风险之间的关联。在衍生队列中,胆固醇酯转移蛋白(CETP)基因的一个遗传变异rs1800777(等位基因A)与较低的HDL-C水平密切相关(17.4 mg / dL与32.9 mg / dL,P = 0.002) ,更高的CETP质量(3.43 µg / mL与1.32 µg / mL,P = 0.034),以及临床上与脓毒症相关的临床显着性AKI风险增加(或:8.28,p = 0.013)。此外,在验证队列中,相同的等位基因是败血症相关性AKI的预测因子(OR:2.38,p = 0.020)。我们的发现表明,CETP调节败血症中的HDL-C水平。 CETP基因型可以识别出败血症相关性AKI的高危患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号